MEDICSKIN (08307) releases its interim performance, with a net profit attributable to shareholders of HK$35,000, turning from a loss to a profit year-on-year.

MEDICSKIN (08307) released its interim performance for the six months ending September 30, 2025. The company achieved revenue of 22.774 million Hong Kong dollars, an increase of 1.97% year-on-year. The net profit attributable to owners of the company was 35,000 Hong Kong dollars, compared to a loss of 2.033 million Hong Kong dollars in the same period last year, turning from loss to profit year-on-year. Earnings per share were 0.01 Hong Kong cents. The announcement stated that the turnaround from loss to profit was mainly attributed to cost savings from depreciation of right-of-use assets (due to reduced rental expenses) and savings in employee costs, both amounting to approximately 1 million Hong Kong dollars each.